cnetsadmin

/cnetsadmin

About cnetsadmin

This author has not yet filled in any details.
So far cnetsadmin has created 52 blog entries.

2019 National NET Patient Conference LIVE-STREAM

Join CNETS Canada 2019 National NET Patient Conference's video & audio conference by clicking the following link: https://freeman.meetngreet.ca/join/x1GxoRj3UO 2019 NATIONAL NET PATIENT CONFERENCE LIVE-STREAM Saturday April 6, 2019 from [...]

By | 2019-03-26T02:23:45+00:00 March 26th, 2019|News|Comments Off on 2019 National NET Patient Conference LIVE-STREAM

CNETS Canada Board of Directors Announcement

As we start 2019 we bid farewell to a long-time board member and welcome three new board members to CNETS Canada’s Board of Directors. We extend our heartfelt gratitude to [...]

By | 2019-03-24T22:30:43+00:00 March 4th, 2019|News|Comments Off on CNETS Canada Board of Directors Announcement

Jackie Herman Elected To The Board of INCA

Our very own Jackie Herman, CNETS Canada President was elected to the International Neuroendocrine Cancer Alliance (INCA) on January 30th, 2019. INCA welcomed 2 new Directors to the INCA [...]

By | 2019-03-24T22:22:42+00:00 January 30th, 2019|News|Comments Off on Jackie Herman Elected To The Board of INCA

Health Canada approves XERMELO™ (telotristat ethyl)

Health Canada approves XERMELO™ (telotristat ethyl) for the treatment of adult patients suffering from refractory carcinoid syndrome diarrhea(1) "XERMELOTM is a novel, orally administered, inhibitor of the enzyme tryptophan hydroxylase [...]

By | 2018-10-17T14:45:09+00:00 October 17th, 2018|Treatment News|Comments Off on Health Canada approves XERMELO™ (telotristat ethyl)

Public Listings for Caprelsa

Caprelsa (vandetanib) is indicated for the treatment of symptomatic or progressive Medullary thyroid cancer in adult patients with unresectable locally advanced or metastatic disease. Alberta Health Services has put the [...]

By | 2018-09-18T23:32:14+00:00 September 18th, 2018|Treatment News|Comments Off on Public Listings for Caprelsa

Patient Input – Treatment with Telotristat

TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]

By | 2018-09-03T18:47:17+00:00 September 3rd, 2018|Survey, Treatment News|Comments Off on Patient Input – Treatment with Telotristat

ARETHA FRANKLIN DIED FROM NEUROENDOCRINE CANCER

RIP THE GREAT ARETHA FRANKLIN Aretha Franklin, the Queen of Soul, passed away from neuroendocrine cancer (NETs) of the pancreas, the very same cancer that killed Apple [...]

By | 2018-09-03T11:14:07+00:00 August 17th, 2018|News|Comments Off on ARETHA FRANKLIN DIED FROM NEUROENDOCRINE CANCER